[Coagulation factors and multiple sclerosis : Key factors in the pathogenesis?]

Area of Science:

• Neuroimmunology
• Hematology
• Coagulation Research

Background:

• Multiple sclerosis (MS) risk is influenced by environmental factors and genetics.
• The coagulation system, including fibrinogen, thrombin, and factor XII, plays a role in MS pathogenesis.
• Dysregulation of coagulation factors is observed in MS patients.

Purpose of the Study:

• To investigate the contribution of the coagulation system to multiple sclerosis (MS) severity.
• To explore the therapeutic potential of targeting coagulation factors in MS models.

Main Methods:

• Utilized experimental autoimmune encephalomyelitis (EAE) as an animal model for MS.
• Investigated the effects of inhibiting fibrinogen and factor XII on disease course.
• Examined coagulation factor dysregulation in MS patients.

Main Results:

• Inhibition of fibrinogen and factor XII significantly improved disease course in EAE models.
• Preclinical studies demonstrate a substantial contribution of the coagulation system to MS severity.
• Coagulation factor dysregulation was identified in patients with MS.

Conclusions:

• The coagulation cascade is a significant contributor to neuroinflammation in MS.
• Targeting fibrinogen and factor XII presents a potential therapeutic strategy for MS.
• Further research is needed to clarify the precise role of coagulation changes in MS pathogenesis and validate findings in human subjects.